Stocks Overview

LAST PRICE
42.2600
TODAY'S CHANGE (%)
Trending Down-0.8500 (-1.9717%)

Bid / Lots
42.0000/ 12
Ask / Lots
42.5000/ 4
Open / Previous Close
42.0500 / 43.1100
Day Range
Low 41.5600
High 42.9300
52 Week Range
Low 31.3600
High 52.9800
Volume
1,264,388
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 43.11
Time	Volume	HALO
09:32 ET	83157	42.89
09:34 ET	2689	42.74
09:36 ET	12372	42.53
09:38 ET	4962	42.2
09:39 ET	4225	42.3571
09:41 ET	4234	42.3339
09:43 ET	3402	42.2723
09:45 ET	12323	42.13
09:48 ET	8363	42.0856
09:50 ET	10817	41.93
09:52 ET	30779	41.66
09:54 ET	3129	41.8072
09:56 ET	3465	41.91
09:57 ET	2274	41.94
09:59 ET	4186	42.02
10:01 ET	2200	41.918
10:03 ET	500	42.04
10:06 ET	4288	42.0975
10:08 ET	800	42.14
10:10 ET	2856	42.24
10:12 ET	7703	42.25
10:14 ET	4310	42.31
10:15 ET	11602	42.2
10:17 ET	1597	42.16
10:19 ET	4991	42.23
10:21 ET	1789	42.37
10:24 ET	3030	42.31
10:26 ET	2455	42.23
10:28 ET	1896	42.26
10:30 ET	2241	42.3
10:32 ET	2530	42.3
10:33 ET	2503	42.39
10:35 ET	4531	42.4799
10:37 ET	700	42.49
10:39 ET	9152	42.54
10:42 ET	1561	42.34
10:44 ET	3070	42.38
10:46 ET	3419	42.3319
10:48 ET	2200	42.47
10:50 ET	4512	42.38
10:51 ET	1495	42.305
10:53 ET	1909	42.2134
10:55 ET	1710	42.185
10:57 ET	5647	42.09
11:00 ET	6061	42.06
11:02 ET	11595	42.08
11:04 ET	2733	42.1
11:06 ET	762	42.12
11:08 ET	3878	42.018
11:09 ET	1409	42.07
11:11 ET	4692	41.94
11:13 ET	4535	41.9845
11:15 ET	1440	42.08
11:18 ET	2850	42.08
11:20 ET	1483	42.17
11:22 ET	3383	42.255
11:24 ET	3357	42.27
11:26 ET	427	42.3195
11:27 ET	9908	42.215
11:29 ET	2025	42.29
11:31 ET	2700	42.32
11:33 ET	635	42.34
11:36 ET	705	42.385
11:38 ET	2514	42.375
11:40 ET	1112	42.44
11:42 ET	479	42.53
11:44 ET	2699	42.5
11:45 ET	900	42.52
11:47 ET	1150	42.51
11:49 ET	3295	42.53
11:51 ET	7580	42.5
11:54 ET	16794	42.43
11:56 ET	2950	42.46
11:58 ET	3278	42.4207
12:00 ET	1685	42.42
12:02 ET	973	42.39
12:03 ET	3522	42.4
12:05 ET	1400	42.41
12:07 ET	2097	42.35
12:09 ET	1256	42.335
12:12 ET	2697	42.3756
12:14 ET	200	42.39
12:16 ET	1302	42.42
12:18 ET	300	42.435
12:20 ET	2957	42.49
12:21 ET	389	42.46
12:23 ET	2800	42.475
12:25 ET	1663	42.53
12:27 ET	600	42.55
12:30 ET	6392	42.516
12:32 ET	2229	42.54
12:34 ET	1851	42.46
12:36 ET	939	42.52
12:38 ET	200	42.54
12:39 ET	500	42.63
12:41 ET	3000	42.57
12:43 ET	735	42.595
12:45 ET	2047	42.66
12:48 ET	1103	42.64
12:50 ET	1724	42.61
12:52 ET	880	42.63
12:54 ET	852	42.68
12:56 ET	400	42.65
12:57 ET	8877	42.7
12:59 ET	814	42.645
01:01 ET	500	42.6636
01:03 ET	1338	42.6
01:06 ET	1800	42.58
01:08 ET	958	42.51
01:10 ET	900	42.49
01:12 ET	1700	42.47
01:14 ET	485	42.47
01:15 ET	1104	42.45
01:17 ET	1002	42.47
01:19 ET	644	42.5
01:21 ET	1000	42.52
01:24 ET	1776	42.505
01:26 ET	404	42.53
01:28 ET	1753	42.5
01:30 ET	1698	42.41
01:32 ET	1600	42.36
01:33 ET	3192	42.4062
01:35 ET	1000	42.39
01:37 ET	1790	42.33
01:39 ET	1500	42.4
01:42 ET	1100	42.39
01:44 ET	1471	42.44
01:46 ET	2000	42.36
01:48 ET	1215	42.4
01:50 ET	100	42.395
01:51 ET	2902	42.34
01:53 ET	1100	42.34
01:55 ET	3280	42.36
01:57 ET	2100	42.38
02:00 ET	4807	42.4201
02:02 ET	915	42.425
02:04 ET	714	42.46
02:06 ET	2425	42.45
02:08 ET	500	42.44
02:09 ET	2665	42.43
02:11 ET	1300	42.445
02:13 ET	800	42.41
02:15 ET	700	42.4182
02:18 ET	200	42.42
02:20 ET	3208	42.39
02:22 ET	1700	42.455
02:24 ET	600	42.49
02:26 ET	1076	42.455
02:27 ET	2401	42.425
02:29 ET	1262	42.46
02:31 ET	700	42.45
02:33 ET	500	42.49
02:36 ET	1000	42.47
02:38 ET	2200	42.4444
02:40 ET	1783	42.48
02:42 ET	1720	42.475
02:44 ET	6415	42.54
02:45 ET	3887	42.54
02:47 ET	531	42.56
02:49 ET	1195	42.57
02:51 ET	3648	42.565
02:54 ET	3240	42.48
02:56 ET	2827	42.46
02:58 ET	1402	42.42
03:00 ET	700	42.4
03:02 ET	1148	42.39
03:03 ET	1502	42.33
03:05 ET	300	42.31
03:07 ET	4290	42.35
03:09 ET	200	42.355
03:12 ET	739	42.38
03:14 ET	6270	42.38
03:16 ET	1916	42.39
03:18 ET	3100	42.41
03:20 ET	6449	42.39
03:21 ET	3966	42.385
03:23 ET	1451	42.31
03:25 ET	2600	42.34
03:27 ET	1730	42.28
03:30 ET	6500	42.29
03:32 ET	2825	42.31
03:34 ET	2600	42.34
03:36 ET	4373	42.355
03:38 ET	3000	42.38
03:39 ET	3430	42.36
03:41 ET	3935	42.42
03:43 ET	5209	42.4208
03:45 ET	5204	42.51
03:48 ET	3450	42.42
03:50 ET	3113	42.41
03:52 ET	4880	42.48
03:54 ET	4673	42.41
03:56 ET	11229	42.36
03:57 ET	14454	42.35
03:59 ET	41373	42.26

Data delayed at least 15 minutes.

Today
- BRIEF-Halozyme Therapeutics Entered Into Amendment No. 1 To Credit Agreement, from 4 hours ago by Thomson Reuters
  4 hours ago by Thomson Reuters
Yesterday
- --Halozyme Therapeutics Completes $720 Million Sale of 1% Convertible Senior Notes due 2028, from 5:19PM ET on Thursday Aug 18, 2022 by MT Newswires
  5:19PM ET on Thursday Aug 18, 2022 by MT Newswires
Aug 16, 2022
- Halozyme Therapeutics Prices Upsized Offering of $625 Million of Convertible Senior Notes, from 4:08AM ET on Tuesday Aug 16, 2022 by MT Newswires
  4:08AM ET on Tuesday Aug 16, 2022 by MT Newswires
Aug 15, 2022
- BRIEF-Halozyme Therapeutics Announced Pricing Of $625.0 Mln Aggregate Principal Amount Of Convertible Senior Notes Due 2028, from 10:35PM ET on Monday Aug 15, 2022 by Thomson Reuters
  10:35PM ET on Monday Aug 15, 2022 by Thomson Reuters
- Halozyme Therapeutics, Inc. Announces Upsize and Pricing of Private Offering of $625 Million of Convertible Senior Notes due 2028, from 10:32PM ET on Monday Aug 15, 2022 by PR Newswire
  10:32PM ET on Monday Aug 15, 2022 by PR Newswire

1 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesHALO Halozyme Therapeutics Inc	6.1B	16.7x	---
United StatesGH Guardant Health Inc	5.4B	-8.8x	---
United StatesAZTA Azenta Inc	4.6B	-151.1x	---
United StatesIONS Ionis Pharmaceuticals Inc	6.5B	-225.3x	---
United StatesCERE Cerevel Therapeutics Holdings Inc	6.2B	-17.2x	---
United StatesMRVI Maravai LifeSciences Holdings Inc	6.7B	12.8x	---
As of 2022-08-19

Halozyme Therapeutics, Inc. is a biopharma technology platform company. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine its ENHANZE drug delivery technology with the collaborators' compounds. The Company's lead enzyme, rHuPH20, is used to facilitate the delivery of injected drugs and fluids. The Company's approved product and its collaborators’ approved products and product candidates are based on rHuPH20, a patented recombinant human hyaluronidase enzyme. The Company's lead product, Hylenex recombinant, is a formulation of rHuPH20 that facilitates subcutaneous fluid administration for achieving hydration, to increase the dispersion and absorption of other injected drugs and, in subcutaneous urography, to improve resorption of radiopaque agents. The rHuPH20 can be applied as a drug delivery platform to increase dispersion and absorption of other injected drugs and fluids, potentially reducing the treatment burden.

Contact Information

Headquarters: 11388 Sorrento Valley RdSAN DIEGO, CA, United States 92121-1345
Phone: 858-794-8889
Fax: 302-655-5049

Executives

Independent Chairman of the Board: Connie Matsui
President, Chief Executive Officer, Director: Helen Torley
Chief Financial Officer, Senior Vice President: Nicole Labrosse
Senior Vice President, Chief Technical Officer: Michael Labarre
Senior Vice President, Chief Compliance Officer, General Counsel, Secretary: Mark Snyder

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

Fundamentals Table
Market Cap	$6.1B
Revenue (TTM)	$487.5M
Shares Outstanding	137.9M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.19
EPS	$2.52
Book Value	$1.43
P/E Ratio	16.7x
Price/Sales (TTM)	12.5
Price/Cash Flow (TTM)	16.0x
Operating Margin	49.61%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Halozyme Therapeutics Inc
NASDAQ:HALOUnited States

Search Criteria

Charts

Recent News

Today

BRIEF-Halozyme Therapeutics Entered Into Amendment No. 1 To Credit Agreement, from 4 hours ago by Thomson Reuters

Yesterday

--Halozyme Therapeutics Completes $720 Million Sale of 1% Convertible Senior Notes due 2028, from 5:19PM ET on Thursday Aug 18, 2022 by MT Newswires

Aug 16, 2022

Halozyme Therapeutics Prices Upsized Offering of $625 Million of Convertible Senior Notes, from 4:08AM ET on Tuesday Aug 16, 2022 by MT Newswires

Aug 15, 2022

BRIEF-Halozyme Therapeutics Announced Pricing Of $625.0 Mln Aggregate Principal Amount Of Convertible Senior Notes Due 2028, from 10:35PM ET on Monday Aug 15, 2022 by Thomson Reuters

Halozyme Therapeutics, Inc. Announces Upsize and Pricing of Private Offering of $625 Million of Convertible Senior Notes due 2028, from 10:32PM ET on Monday Aug 15, 2022 by PR Newswire

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar